Treatment of complex chronic conditions, such as rheumatoid arthritis, has led to the development of novel therapeutic drugs.1 However, these specialty medications come at a cost to the patient, and recent data indicate that higher cost-sharing is associated with reductions in the use of these drugs.
A single fracture of any proximal bone increases the risk of premature death, according to an observational study reported at the 2015 annual meeting of the American College of Rheumatology.
A clearer picture is emerging of evidence-based, nondrug treatments for patients with juvenile idiopathic arthritis (JIA), thanks to a recent article on foot care for youth suffering from the common chronic condition—which is associated with pain, deformities, and malalignment in the feet—published online ahead of print.
Ultrasound (US) was of no added value in determining remission in a randomized study of patients with rheumatoid arthritis (RA) who were managed with a treat-to-target (T2T) strategy, suggesting that it can be safely omitted for serial monitoring to assess remission. There was no difference in the probability of achieving sustained clinical remission and stopping radiographic progression between a strategy employing US and a conventional strategy (CS) based on clinical and labora­tory assessments alone.
Smoking is a risk factor for a wide variety of conditions. In a recent study, investigators found that smoking is associated with more early evidence of interstitial lung disease than in healthy patients without rheumatoid arthritis (RA).
Although the obesity rate has been steadily increasing since the 1960s, with 1 in 3 adults currently classified as obese in the United States, Maria M. Wertli, MD, PhD, Research Fellow, Horten Centre for Patient Oriented Research and Knowledge Transfer, Department of Internal Medicine, University of Zurich, Switzerland, and colleagues assert that the impact of being overweight and obese on the working population is yet to be wholly realized.
A large proportion of patients with gout have uncontrolled disease, according to recent research published in The Journal of Rheumatology. These patients have significantly worse functioning, quality of life, and work productivity.
Page 2 of 2
Results 11 - 17 of 17
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology